NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Physician- and Patient-based Barriers to NGS Testing
Physician- and Patient-based Barriers to NGS Testing
RecruitingNA
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions: Metastatic Prostate Cancer
Interventions: Provider-level and patient education at end of study, Provider-level and patient-level
Countries: United States
The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.
Eligibility overview
Sex: MALE
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * men diagnosed with metastatic prostate cancer * seen by Johns Hopkins Medical Oncology as a new patient visit between January 1, 2025 and December 31, 2026 Exclusion Criteria: \- Patients who have already had NGS testing performed.
Locations (1)
- Baltimore, Maryland, United States